Clinical and nonclinical correlates of racial and ethnic differences in recommendation patterns for coronary

J M Barnhart1, S Wassertheil-Smoller, E S Monrad

  • 1Department of Epidemiology, Albert Einstein College of Medicine, Bronx, New York, USA.

Clinical Cardiology
|August 15, 2000
PubMed

Insights

Racial disparities exist in coronary revascularization recommendations. Hispanics with severe coronary artery disease were less likely to be recommended for procedures like angioplasty or bypass surgery.

Area of Science:

  • Cardiology
  • Health Disparities
  • Medical Outcomes

Background:

  • Investigated potential gender and racial differences in coronary revascularization recommendations.
  • Focused on a multiracial patient cohort undergoing initial coronary angiography for coronary artery disease (CAD) evaluation.
  • Study period: 1990-1993 at an academic institution.

Purpose of the Study:

  • To determine if race or gender influences recommendations for coronary revascularization.
  • Hypothesized no racial differences in revascularization recommendations for patients with significant CAD.

Main Methods:

  • Analyzed recommendations for percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass graft (CABG) in 590 patients with significant CAD.
  • Primary analysis focused on 180 patients with severe CAD (triple-vessel or left main disease).
  • Controlled for age, gender, ejection fraction, angina, diabetes, hypertension, and peripheral vascular disease; race categorized as Hispanic, black, and white.

Main Results:

  • Hispanics with severe CAD were significantly less likely than whites to be recommended for PTCA/CABG (OR=0.39).
  • Black patients showed a trend towards lower recommendation rates compared to whites (OR=0.67).
  • Medical record review of patients not recommended for revascularization revealed reasons including subsequent ischemic events, disease severity precluding intervention, or patient preference for medical therapy.

Conclusions:

  • Racial differences were observed in revascularization recommendations following coronary angiography.
  • These disparities may be attributed to unmeasured clinical and nonclinical factors.
Abstract

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...